IF 3.1 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Yeke Wu, Jiawei Li, Min Liu, Ranran Gao, Yunfei Xie, Huijing Li, Li Li
{"title":"The active ingredients and targets of Kouqiangjie formula on periodontitis: a multi-approach study.","authors":"Yeke Wu, Jiawei Li, Min Liu, Ranran Gao, Yunfei Xie, Huijing Li, Li Li","doi":"10.1007/s00210-025-03942-1","DOIUrl":null,"url":null,"abstract":"<p><p>Periodontitis (PD) is a complex oral inflammatory disease with diverse pathogenic factors, demanding effective multi-target therapeutic approaches. Traditional Chinese Medicine (TCM) formulations, like the Kouqiangjie Formula (KQJF), hold potential as alternative therapies due to their multiple pharmacological effects. This study comprehensively investigated the key active ingredients and molecular targets of KQJF in treating PD through a combination of network pharmacology, machine learning, Mendelian randomization (MR), and experimental validation. The active components and targets of KQJF were identified via the TCMSP and HERB databases, while PD-related genes were sourced from GeneCards, CTD, and DisGeNET. Gene expression data from GEO datasets enabled differential expression analysis. Machine learning models, including Random Forest (RF) and Support Vector Machine (SVM), were employed to evaluate the diagnostic potential of gene sets. Molecular docking was utilized to assess the interactions between active ingredients and targets, and MR analysis was conducted to explore the causal relationships with PD. Experimental validation was carried out using a rat model. The results indicated that KQJF consists of 193 active compounds that target 561 proteins, with a significant overlap of 272 targets related to PD. Key compounds such as luteolin, linolenic acid, and naringenin were identified. The SVM model demonstrated excellent predictive performance, with an AUC of 0.954. MR analysis revealed a significant causal effect of the CASP3 gene on the risk of PD (OR = 1.595, p = 0.015). Experimental findings showed that these compounds could reduce the expression of CASP3 and improve the integrity of periodontal tissues. In conclusion, luteolin, linolenic acid, and naringenin are the core compounds in KQJF, and CASP3 is an important target. This study emphasizes the great potential of KQJF for PD treatment and provides a solid data base for the development of new therapeutic strategies.</p>","PeriodicalId":18876,"journal":{"name":"Naunyn-Schmiedeberg's archives of pharmacology","volume":" ","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Naunyn-Schmiedeberg's archives of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00210-025-03942-1","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

牙周炎(PD)是一种复杂的口腔炎症性疾病,致病因素多种多样,需要有效的多靶点治疗方法。传统中药配方,如口腔溃疡方(KQJF),因其多种药理作用而具有替代疗法的潜力。本研究结合网络药理学、机器学习、孟德尔随机化(MR)和实验验证等方法,全面研究了口强绝方治疗帕金森病的关键活性成分和分子靶点。KQJF的活性成分和靶点通过TCMSP和HERB数据库确定,而与PD相关的基因则来自GeneCards、CTD和DisGeNET。来自 GEO 数据集的基因表达数据实现了差异表达分析。采用随机森林(RF)和支持向量机(SVM)等机器学习模型来评估基因组的诊断潜力。利用分子对接评估了活性成分与靶点之间的相互作用,并进行了MR分析以探索与PD的因果关系。利用大鼠模型进行了实验验证。结果表明,KQJF由193个活性化合物组成,靶向561个蛋白质,其中272个靶点与帕金森病有显著重叠。其中发现了叶黄素、亚麻酸和柚皮苷等关键化合物。SVM 模型具有出色的预测性能,AUC 为 0.954。MR分析显示,CASP3基因对罹患帕金森病的风险有明显的因果效应(OR = 1.595,p = 0.015)。实验结果表明,这些化合物可以降低 CASP3 的表达,改善牙周组织的完整性。总之,叶黄素、亚麻酸和柚皮苷是 KQJF 的核心化合物,而 CASP3 是一个重要的靶点。本研究强调了 KQJF 治疗 PD 的巨大潜力,并为开发新的治疗策略提供了坚实的数据基础。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The active ingredients and targets of Kouqiangjie formula on periodontitis: a multi-approach study.

Periodontitis (PD) is a complex oral inflammatory disease with diverse pathogenic factors, demanding effective multi-target therapeutic approaches. Traditional Chinese Medicine (TCM) formulations, like the Kouqiangjie Formula (KQJF), hold potential as alternative therapies due to their multiple pharmacological effects. This study comprehensively investigated the key active ingredients and molecular targets of KQJF in treating PD through a combination of network pharmacology, machine learning, Mendelian randomization (MR), and experimental validation. The active components and targets of KQJF were identified via the TCMSP and HERB databases, while PD-related genes were sourced from GeneCards, CTD, and DisGeNET. Gene expression data from GEO datasets enabled differential expression analysis. Machine learning models, including Random Forest (RF) and Support Vector Machine (SVM), were employed to evaluate the diagnostic potential of gene sets. Molecular docking was utilized to assess the interactions between active ingredients and targets, and MR analysis was conducted to explore the causal relationships with PD. Experimental validation was carried out using a rat model. The results indicated that KQJF consists of 193 active compounds that target 561 proteins, with a significant overlap of 272 targets related to PD. Key compounds such as luteolin, linolenic acid, and naringenin were identified. The SVM model demonstrated excellent predictive performance, with an AUC of 0.954. MR analysis revealed a significant causal effect of the CASP3 gene on the risk of PD (OR = 1.595, p = 0.015). Experimental findings showed that these compounds could reduce the expression of CASP3 and improve the integrity of periodontal tissues. In conclusion, luteolin, linolenic acid, and naringenin are the core compounds in KQJF, and CASP3 is an important target. This study emphasizes the great potential of KQJF for PD treatment and provides a solid data base for the development of new therapeutic strategies.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.20
自引率
5.60%
发文量
142
审稿时长
4-8 weeks
期刊介绍: Naunyn-Schmiedeberg''s Archives of Pharmacology was founded in 1873 by B. Naunyn, O. Schmiedeberg and E. Klebs as Archiv für experimentelle Pathologie und Pharmakologie, is the offical journal of the German Society of Experimental and Clinical Pharmacology and Toxicology (Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie, DGPT) and the Sphingolipid Club. The journal publishes invited reviews, original articles, short communications and meeting reports and appears monthly. Naunyn-Schmiedeberg''s Archives of Pharmacology welcomes manuscripts for consideration of publication that report new and significant information on drug action and toxicity of chemical compounds. Thus, its scope covers all fields of experimental and clinical pharmacology as well as toxicology and includes studies in the fields of neuropharmacology and cardiovascular pharmacology as well as those describing drug actions at the cellular, biochemical and molecular levels. Moreover, submission of clinical trials with healthy volunteers or patients is encouraged. Short communications provide a means for rapid publication of significant findings of current interest that represent a conceptual advance in the field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信